OrthoPediatrics (OrthoPediatrics) Cash And Cash Equivalents : $21.6 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics Cash And Cash Equivalents?

OrthoPediatrics's quarterly cash and cash equivalents increased from Sep. 2023 ($10.64 Mil) to Dec. 2023 ($31.06 Mil) but then stayed the same from Dec. 2023 ($31.06 Mil) to Mar. 2024 ($21.60 Mil).

OrthoPediatrics's annual cash and cash equivalents increased from Dec. 2021 ($7.64 Mil) to Dec. 2022 ($8.99 Mil) and increased from Dec. 2022 ($8.99 Mil) to Dec. 2023 ($31.06 Mil).

OrthoPediatrics Cash And Cash Equivalents Historical Data

The historical data trend for OrthoPediatrics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrthoPediatrics Cash And Cash Equivalents Chart

OrthoPediatrics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

70.78

28.76

7.64

8.99

31.06

OrthoPediatrics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															34.66	9.71	10.64	31.06	21.60

OrthoPediatrics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

OrthoPediatrics (NAS:KIDS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

OrthoPediatrics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

OrthoPediatrics (OrthoPediatrics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

2X7:Germany

Address

2850 Frontier Drive, Warsaw, IN, USA, 46582

Website

https://www.orthopediatrics.com

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Executives

Terry D Schlotterback	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Fred Hite	director, officer: Chief Financial Officer	ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
Dyer George Sinclair Mitchell	director	55 ORCHARD ST., CAMBRIDGE MA 02140
Gregory A Odle	officer: Executive Vice President	2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser	officer: Sr VP & GM Trauma & Deformity	6428 RIDGELINE DR, HUDSON OH 44236
Jimmy Duane Mcdonald	director	28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc	10 percent owner	18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc	10 percent owner	2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf	director	2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C	director	2850 FRONTIER DR, WARSAW IN 46582
Stephen F Burns	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Berry Bernie B Iii	director	2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl	director, officer: President and CEO	ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582